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Purpose: To detect paired box gene 3 (PAX3) mutations and associated phenotypes in Chinese patients with Waardenburg
syndrome type 1 (WS1).
Methods: Five unrelated families with suspected WS1 were selected from our Genomic DNA Repository for Hereditary
Eye Diseases. The coding and adjacent intronic regions of PAX3 were amplified by polymerase chain reaction and the
amplicons were then analyzed by cycle sequencing. Variations detected were further evaluated in available family
members as well as one hundred controls with heteroduplex-single strand conformational polymorphism (heteroduplex-
SSCP) analysis and/or clone sequencing.
Results: Three novel and two known mutations in PAX3 were detected in five patients, respectively: c.567_586+17del
(p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly), c.456_459dupTTCC (p.Ile154PhefsX162), c.795_800delCTGGTT
(p.Trp266_Phe267del), c.799T>A (p.Phe267Ile), and c.667C>T (p.Arg223X). Two novel mutations proved to be de novo
as their parents did not carry the mutations. All five patients with PAX3 mutations had dystopia canthorum and different
iris color and fundi between their two eyes. However, none had white forelock, skin hypopigmentation, and deafness.
Conclusions: Our findings expand the frequency and spectrum of PAX3 mutations and ethnic-related phenotypes in
Chinese patients with WS1. De novo mutations in PAX3 have not been reported before.
Waardenburg syndrome (WS) is an inherited disorder
characterized  by  varying  degrees  of  hearing  loss  and
pigmentary anomalies affecting the eye, hair, and skin [1-6].
WS is clinically heterogeneous and has been classified into
four major types and 10 subtypes as listed in Table 1 [5,
7-17]. WS type 1 (WS1, OMIM 193500) and type 2 (WS2)
are more common than type 3 (WS3) and type 4 (WS4).
Overall, the syndrome affects perhaps 1 in 42,000 people [6].
Except  for  auditory-pigmentary  disorder,  dystopia
canthorum  is  the  typical  phenotype  of  WS1  (Table  1).
Mutations in the paired box gene 3 (PAX3, OMIM 606597)
have been identified to be responsible for WS1 [18,19]. PAX3
encodes  a  member  of  the  mammalian  PAX  family  of
transcription factors, which contains two highly conserved
domains for DNA binding, paired box domain and paired-type
homeodomain [20]. Alternative splicing of PAX3 results in
several  different-length  transcripts,  of  which  the  longest
transcript contains 10 exons, and consequent proteins with
distinct carboxyl termini [21]. PAX3 plays a regulatory role
in the early embryonic development of the pigment system
[22]  and  is  required  to  expand  a  pool  of  committed
melanoblasts  or  restricted  progenitor  cells  early  in
development  [23].  Heterozygous  mutations  in  PAX3  have
been  reported  in  familial  and  sporadic  WS1,  while
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heterozygous or homozygous mutations have been detected
in patients with WS3 [8,13,24,25]. Although many mutations
have been identified in Caucasians, several cases have been
determined  in  the  Chinese  population  [26,27].  Fundus
changes for WS1 patients with PAX3 mutations have not been
reported.
In the present study, five mutations in PAX3, including
three novel ones and two known ones, were identified in five
unrelated Chinese families with WS1. All patients with the 5
mutations presented dystopia canthorum and different colors
of  the  irises  and  fundi  but  none  of  those  showed  visible
pigmentary changes on their hair and skin, indicating an ethnic
specific phenotypes.
METHODS
Patients:  Five  unrelated  patients  were  recruited  from  our
Pediatric  and  Genetic  Eye  Clinic,  Zhongshan  Ophthalmic
Center, Guangzhou, P.R. China. Diagnosis of WS1 was based
on  criteria  previously  described  [4,28].  Informed  consent
conforming to the tenets of the Declaration of Helsinki and
following  the  Guidance  of  Sample  Collection  of  Human
Genetic  Diseases  (National  863-Plan)  by  the  Ministry  of
Public  Health  of  China  was  obtained  from  participating
individuals before the study. All participants received detailed
ophthalmological  examinations  performed  by
ophthalmologists (Q.Z. or X.G.). Unrelated controls (100)
were  collected  from  normal  volunteers.  This  study  was
approved by the Institutional Review Board of Zhongshan
Ophthalmic Center.
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1146Variation analysis: Genomic DNA was isolated from venous
leukocytes. Genomic fragments encompassing coding regions
and adjacent intronic regions of PAX3 were amplified by
polymerase chain reaction (PCR), using eleven primer pairs
(PAX3: NCBI human genome build 36.1, NC_000002.11,
NM_181459.2, NP_852124.1), including previously reported
primers for exons 1–9 [26] and two new primer pairs for exon
10  (Table  2).  The  amplicons  from  individual  exon  were
purified and analyzed by cycle sequencing with ABI BigDye
Terminator  Cycle  Sequencing  Kit  v3.1  (ABI  Applied
Biosystems,  Foster  City,  CA)  on  an  automatic  DNA
sequencer  (ABI  3100  Genetic  Analyzer,  Applied
Biosystems). Sequencing results from patients as well as the
consensus  sequences  from  the  NCBI  Human  Genome
Database were imported into the SeqManII program of the
Lasergene package (DNAStar Inc., Madison, WI) and aligned
to  identify  variations.  Each  variation  was  confirmed  by
bidirectional sequencing. Variations were named following
the  nomenclature  recommended  by  the  Human  Genomic
Variation Society (HGVS).
Any variation detected by sequence analysis was further
evaluated in 100 controls by heteroduplex-SSCP analysis. In
addition,  one  multiple-nucleotide  deletion  was  further
analyzed by clone sequencing, using the method we described
previously [29]. NNSPLICE  version  0.9  was used to predict
splice sites.
RESULTS
Clinical  phenotype:  The  most  significant  sign  in  all  five
unrelated patients is different colors between two eyes, which
resulted from heterochromia iridis (Figure 1, Table 3). All
patients had dystopia canthorum (Figure 1). Ocular fundus
examination  revealed  different  colors  between  two  fundi
(Figure 2), which have not been described before. In all 5
patients the eye with generalized iris hypopigmentation also
had  mild  retinal  hypopigmentation.  In  the  eyes  with
pigmentary changes, however, the fundus vessel distribution,
macular architectural and visual acuity seemed to be normal
(Figure 2 and Table 3). None of the 5 patients had pigmentary
changes on their skin, hair, eyebrows, and eyelashes, which
are the common signs in Caucasian patients. Deafness was not
TABLE 1. CLASSIFICATION OF WAARDENBURG SYNDROME.
Phenotypes
Types OMIM Inheritance 1 2 345 Genes or loci Reference
WS1 193500 AD + +/−* + - - PAX3 [8]
WS2     + +/−** ---    
WS2A 193510 AD + + --- MITF [9]
WS2B 600193 AD + + --- 1p21-p13.3 [17]
WS2C 606662 AD + + --- 8p23 [10]
WS2D 608890 AR + + --- SNAI2 [11]
WS2E 611584 AD + + --- SOX10 [12]
WS3 148820 AD or AR + + + + - PAX3 [13]
WS4     + + - - +    
WS4A 277580 AR or AD + +/− - - + EDNRB [14]
WS4B 613265 AR or AD + + - - + EDN3 [15]
WS4C 613266 AD + + - - + SOX10 [16]
Note: Phenotype 1: pigmentary disturbance of skin, hair and iris; Phenotype 2: Deafness; Phenotype 3: dystopia canthorum;
Phenotype 4: upper limb abnormalities; Phenotype 5: aganglionic megacolon. The asterisk indicates presence in about 1/5 cases
and the double asterisk indicates presence in about 3/4 cases.
TABLE 2. PRIMERS FOR AMPLIFYING AND SEQUENCING PAX3 GENOMIC FRAGMENTS.
Exon Forward Primers(5′-3′) Reverse Primers(5′-3′)
Product
size (bp)
Annealing
temperature (°C)
PAX3-ex1 TCACCACAGGAGGAGACTCA GAGGCCCTCCCTTACCTTC 472 60
PAX3-ex2 TACGTGCTGCTGTTCTTTGC TTACGCACCTTCACAAACCTC 442 60
PAX3-ex3 TCTGGTCTGCCCCTTTCTAA ATTGGGGTGATTACGTCTGG 388 60
PAX3-ex4 GCTGGAGAAGGATGAGGATG CTCCAAGTGACCCAGCAAGT 351 60
PAX3-ex5 TGTCTTGCAGTCGGAGAGAG GGTGGACTTCTGTGTGTCGT 492 60
PAX3-ex6 AATTCGCCCAAACAACACA CAGAGAAATCGCCTGGAAGT 368 60
PAX3-ex7 TGGCGATGAACTTTTGCAC GGGTGGAGAGAAAGGAAACC 451 60
PAX3-ex8 TCGTCGGGCATGATGTAATA AGGAGAAATTGCCCCCTAAA 359 60
PAX3-ex9 GAATTGTCCCAGCATGACCT TGCTCCAGGTCTTCCTCTTC 311 62
PAX3-ex10a ACTGGCCCTGTTTCTGGTCT TGGCAAACATCACTGCACTC 943 60
PAX3-ex10b CCAGTTCACATTTATTTGG CTCATAGAAAGGGTCCAC 887 60
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1147observed in three patients while the hearing function could not
be measured in the other two babies. Anomalies on limb
development were not observed in all 5 patients.
Variation  detection:  In  the  5  patients,  five  heterozygous
mutations in PAX3 were detected, including c.567_586+17del
(p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly),  c.456_
459dupTTCC (p.Ile154PhefsX162), c.795_800 delCTGGTT
(p.Trp266_Phe267del),  c.799T>A  (p.Phe267Ile),  and  c.
667C>T  (p.Arg223X;  Table  3,  Figure  3).  The  first  three
mutations were novel and, therefore, were further confirmed
by heteroduplex-SSCP analysis (Figure 3). The other two
mutations were known mutations. All five mutations were
absent in 100 normal controls based on heteroduplex-SSCP
analysis (data not shown).
The c.567_586+17del mutation was identified in a baby
from  Family  A  (A-II:1).  Direct  sequencing  revealed  a
heterozygous variation involving multiple nucleotides in exon
4  region.  Cloning  sequencing  revealed  a  37  bp  deletion
affecting both exon 4 and intron 4 (Figure 3A). A new splice
site is predicted to be created downstream by NNSPLICE. The
encoded protein would be truncated.
The  c.456_459dupTTCC  and  c.795_800delCTGGTT
mutations were only present in the probands (Figure 3, B-II:
Figure 1. Photographs of eyes from WS1 patients and controls. A: Baby with normal iris pigmentation and normal facial characteristics. B:
15-month-old girl (II:1 from family A in Figure 3) with dystopia canthorum, heterochromia iridis, broad nasal root, and a horizontal distance
between the inner canthi of 28 mm. C: Normal adult (I:2 from family A). D, E: Adult II:1 from family E showed dystopia canthorum,
heterochromia iridis (left iris).
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11491, C-II:1) but not in their parents, demonstrating de novo
mutations that have been rarely reported in PAX3.
DISCUSSION
In this study, three novel and two known mutations in PAX3
were identified in five unrelated Chinese patients. The three
novel mutations would result in frameshift or inframe deletion
if  transcribed  and  translated,  suggesting  putative  disease-
causing. Unilateral sapphire iris with pink pupil and retinal
depigmentation as well as dystopia canthorum without other
abnormalities suggested a diagnosis of WS1.
Of  the  five  PAX3  mutations,  three  were  novel  (c.
567_586+17del,  c.456_459dupTTCC  and  c.
795_800delCTGGTT)  and  the  other  two  were  previously
reported  (c.799T>A  and  c.667C>T)  [30,31].  Two  novel
mutations, c.456_459dupTTCC and c.795_800delCTGGTT,
were proved to be de novo as their parents did not carry the
mutations, suggesting that natural occurring new mutations in
PAX3 of the Chinese population is not uncommon. Based on
available information, de novo mutations in PAX3 have rarely
been  mentioned  before.  Three  of  the  five  mutations,  c.
567_586+17del
(p.Asp189_Gln505delinsGluGlyGlyAlaLeuAlaGly),  c.
456_459dupTTCC  (p.Ile154PhefsX162)  and  c.667C>T
(p.Arg223X), are predicted to encode premature truncated
proteins affecting the paired-type homeodomain [20]. The
other  two  mutations,  c.795_800delCTGGTT
(p.Trp266_Phe267del) and c.799T>A (p.Phe267Ile), would
also affect the paired-type homeodomain, if translated.
Clinical  manifestation  of  the  5  Chinese  patients  with
PAX3 mutations is consistent with the phenotypes of WS1.
However, pigmentary changes on skin, hair, eyebrows, and
eyelashes are absent in these Chinese patients, indicating an
ethnic  specific  variations  in  clinical  expression.  Fundus
hypopigmentation in WS1 patients have been demonstrated
in the Chinese patients. Although fundus hypopigmentation
Figure 2. Photographs of fundi from WS1 patients with PAX3 mutations. Fundus photos were taken from the right (OD) and the left (OS)
eyes of two patients, II:1 from family C and II:1 from family E. The colors of fundus photos were different between two eyes in both patients,
where mild retinal hypopigmentation was demonstrated in the left eyes of both patients. The difference of fundus colors between C_II:1 and
E_II:1  is  of  no  clinical  significance  as  different  fundus  cameras  were  used.  Except  for  hypopigmentation,  the  fundus  structure  was
comparatively normal in the patients.
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1150was  recorded  in  WS  in  previous  reports,  it  has  not  been
described  in  WS1  patients  with  PAX3  mutations  before.
Understanding the typical and atypical phenotypes of Chinese
WS1 patients is of clinical importance as such patients may
be  misdiagnosed  as  unilateral  ocular  albinism,  especially
since mild dystopia canthorum is not uncommon in Southern
Chinese population.
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Figure 3. Pedigrees and sequence chromatography. Black filled symbols represented individuals affected with WS1 in each family. Arrow
indicated the proband in each family. A: Clone sequencing demonstrated a c.567_586+17del mutation in Family A. For the other four families,
bidirectional sequencing results were shown for the regions with variations. Underline below the sequence highlighted the codon affected by
the mutation. Gel electrophoresis band patterns below the pedigrees of families A, B, and C were the results of heteroduplex-SSCP analysis,
which  demonstrated  the  presence  and  absence  of  three  novel  mutations  in  other  family  members.  The  c.456_459dupTTCC  and  c.
795_800delCTGGTT mutations in the probands from families B and C were not detected in their parents, suggesting de novo mutations. The
c.567_586+17del mutation in Family A was not present in the patient’s father but sample from her mother was not available. For families D
and E, genomic samples from other family members were not available.
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